{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:20:08Z","timestamp":1781662808735,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0792-5","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T10:02:46Z","timestamp":1566986566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Telomere alterations in neurofibromatosis type 1-associated solid tumors"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-1219","authenticated-orcid":false,"given":"Fausto J.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy K.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Brosnan-Cashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Adelita","family":"Vizcaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen N.","family":"Palsgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Pekmezci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Gokden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"No\u00eb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Pratilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Belzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Heaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"792_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s40064-015-1606-2","volume":"4","author":"K Akaike","year":"2015","unstructured":"Akaike K, Toda-Ishii M, Suehara Y, Mukaihara K, Kubota D, Mitani K, Takagi T, Kaneko K, Yao T, Saito T (2015) TERT promoter mutations are a rare event in gastrointestinal stromal tumors. Springerplus 4:836. \n                    https:\/\/doi.org\/10.1186\/s40064-015-1606-2","journal-title":"Springerplus"},{"key":"792_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.3781","volume":"49","author":"FP Barthel","year":"2017","unstructured":"Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB, Akdemir KC, Seth S, Song X, Wang Q et al (2017) Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet 49:349\u2013357. \n                    https:\/\/doi.org\/10.1038\/ng.3781","journal-title":"Nat Genet"},{"key":"792_CR3","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1402121","journal-title":"N Engl J Med"},{"key":"792_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","volume":"10","author":"H Brems","year":"2009","unstructured":"Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10:508\u2013515. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(09)70033-6","journal-title":"Lancet Oncol"},{"key":"792_CR5","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1402121","journal-title":"N Engl J Med"},{"key":"792_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"792_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","volume":"9","author":"P Chudasama","year":"2018","unstructured":"Chudasama P, Mughal SS, Sanders MA, Hubschmann D, Chung I, Deeg KI, Wong SH, Rabe S, Hlevnjak M, Zapatka M et al (2018) Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun 9:144. \n                    https:\/\/doi.org\/10.1038\/s41467-017-02602-0","journal-title":"Nat Commun"},{"issue":"1","key":"792_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41591-018-0263-8","volume":"25","author":"Fulvio D\u2019Angelo","year":"2018","unstructured":"D\u2019Angelo F, Ceccarelli M, Tala GL, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L et al (2018) The molecular landscape of glioma in patients with Neurofibromatosis 1. Nat Med: Doi. \n                    https:\/\/doi.org\/10.1038\/s41591-018-0263-8","journal-title":"Nature Medicine"},{"key":"792_CR9","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41467-018-04448-6","volume":"9","author":"BH Diplas","year":"2018","unstructured":"Diplas BH, He X, Brosnan-Cashman JA, Liu H, Chen LH, Wang Z, Moure CJ, Killela PJ, Loriaux DB, Lipp ES et al (2018) The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma. Nat Commun 9:2087. \n                    https:\/\/doi.org\/10.1038\/s41467-018-04448-6","journal-title":"Nat Commun"},{"key":"792_CR10","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D'Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K et al (2015) Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun 6:6140. \n                    https:\/\/doi.org\/10.1038\/ncomms7140","journal-title":"Nat Commun"},{"key":"792_CR11","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. \n                    https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"key":"792_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1207313","volume":"333","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425. \n                    https:\/\/doi.org\/10.1126\/science.1207313","journal-title":"Science"},{"key":"792_CR13","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","volume":"179","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH et al (2011) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608\u20131615. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.018","journal-title":"Am J Pathol"},{"key":"792_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1158\/2159-8290.CD-13-0135","volume":"3","author":"CM Heaphy","year":"2013","unstructured":"Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL et al (2013) Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov 3:1130\u20131141. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0135","journal-title":"Cancer Discov"},{"key":"792_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/cncr.30455","volume":"123","author":"AC Hirbe","year":"2017","unstructured":"Hirbe AC, Kaushal M, Sharma MK, Dahiya S, Pekmezci M, Perry A, Gutmann DH (2017) Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Cancer 123:1194\u20131201. \n                    https:\/\/doi.org\/10.1002\/cncr.30455","journal-title":"Cancer"},{"key":"792_CR16","first-page":"43","volume":"4","author":"M Jentoft","year":"2010","unstructured":"Jentoft M, Giannini C, Cen L, Scheithauer BW, Hoesley B, Sarkaria JN, Abell-Aleff PC, Rodriguez EF, Li Y, Rodriguez FJ (2010) Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset. Int J Clin Exp Pathol 4:43\u201357","journal-title":"Int J Clin Exp Pathol"},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","volume":"25","author":"S Job","year":"2019","unstructured":"Job S, Draskovic I, Burnichon N, Buffet A, Cros J, Lepine C, Venisse A, Robidel E, Verkarre V, Meatchi T et al (2019) Telomerase activation and ATRX mutations are independent risk factors for metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res 25:760\u2013770. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0139","journal-title":"Clin Cancer Res"},{"key":"792_CR18","doi-asserted-by":"publisher","first-page":"40132","DOI":"10.18632\/oncotarget.16981","volume":"8","author":"RE Jones","year":"2017","unstructured":"Jones RE, Grimstead JW, Sedani A, Baird D, Upadhyaya M (2017) Telomere erosion in NF1 tumorigenesis. Oncotarget 8:40132\u201340139. \n                    https:\/\/doi.org\/10.18632\/oncotarget.16981","journal-title":"Oncotarget"},{"key":"792_CR19","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC et al (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A 110:6021\u20136026. \n                    https:\/\/doi.org\/10.1073\/pnas.1303607110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"792_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-015-1493-1","volume":"131","author":"A Korshunov","year":"2016","unstructured":"Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V, Sturm D, Meyer J, Jones C, Zheludkova O et al (2016) Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131:137\u2013146. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1493-1","journal-title":"Acta Neuropathol"},{"key":"792_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A et al (2014) PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet 46:1227\u20131232. \n                    https:\/\/doi.org\/10.1038\/ng.3095","journal-title":"Nat Genet"},{"key":"792_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/modpathol.2015.114","volume":"28","author":"JY Liau","year":"2015","unstructured":"Liau JY, Lee JC, Tsai JH, Yang CY, Liu TL, Ke ZL, Hsu HH, Jeng YM (2015) Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas. Mod Pathol 28:1545\u20131554. \n                    https:\/\/doi.org\/10.1038\/modpathol.2015.114","journal-title":"Mod Pathol"},{"key":"792_CR23","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (2016) WHO classification of Tumours of the central nervous system. Revised 4th edition edn. International Agency for Research on Cancer, City"},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"23018","DOI":"10.18632\/oncotarget.25195","volume":"9","author":"HC Lu","year":"2018","unstructured":"Lu HC, Eulo V, Apicelli AJ, Pekmezci M, Tao Y, Luo J, Hirbe AC, Dahiya S (2018) Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST. Oncotarget 9:23018\u201323028. \n                    https:\/\/doi.org\/10.18632\/oncotarget.25195","journal-title":"Oncotarget"},{"key":"792_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/gcc.20525","volume":"47","author":"KK Mantripragada","year":"2008","unstructured":"Mantripragada KK, Caley M, Stephens P, Jones CJ, Kluwe L, Guha A, Mautner V, Upadhyaya M (2008) Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals. Genes Chromosomes Cancer 47:238\u2013246. \n                    https:\/\/doi.org\/10.1002\/gcc.20525","journal-title":"Genes Chromosomes Cancer"},{"key":"792_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","volume":"67","author":"MM Miettinen","year":"2017","unstructured":"Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D et al (2017) Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol 67:1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2017.05.010","journal-title":"Hum Pathol"},{"key":"792_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"National Institutes of Health Consensus Development Conference Statement","year":"1988","unstructured":"National Institutes of Health Consensus Development Conference Statement (1988) Neurofibromatosis. Arch Neurol 45:575\u2013578","journal-title":"Arch Neurol"},{"key":"792_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1750-3639.2012.00630.x","volume":"23","author":"DN Nguyen","year":"2013","unstructured":"Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ (2013) Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol 23:237\u2013243. \n                    https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00630.x","journal-title":"Brain Pathol"},{"key":"792_CR29","doi-asserted-by":"crossref","unstructured":"Nix JS, Blakeley J, Rodriguez FJ (2019) An update on the central nervous system manifestations of Neurofibromatosis type 1. Acta Neuropathol","DOI":"10.1007\/s00401-019-02002-2"},{"key":"792_CR30","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","volume":"91","author":"N Ortonne","year":"2018","unstructured":"Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A et al (2018) Cutaneous neurofibromas: current clinical and pathologic issues. Neurology 91:S5\u2013S13. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000005792","journal-title":"Neurology"},{"key":"792_CR31","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41379-018-0103-x","volume":"31","author":"DN Palsgrove","year":"2018","unstructured":"Palsgrove DN, Brosnan-Cashman JA, Giannini C, Raghunathan A, Jentoft M, Bettegowda C, Gokden M, Lin D, Yuan M, Lin MT et al (2018) Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Mod Pathol 31:1787\u20131800. \n                    https:\/\/doi.org\/10.1038\/s41379-018-0103-x","journal-title":"Mod Pathol"},{"key":"792_CR32","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/modpathol.2017.97","volume":"30","author":"M Pekmezci","year":"2017","unstructured":"Pekmezci M, Cuevas-Ocampo AK, Perry A, Horvai AE (2017) Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors. Mod Pathol 30:1710\u20131719. \n                    https:\/\/doi.org\/10.1038\/modpathol.2017.97","journal-title":"Mod Pathol"},{"key":"792_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","volume":"40","author":"CN Prieto-Granada","year":"2016","unstructured":"Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40:479\u2013489. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000564","journal-title":"Am J Surg Pathol"},{"key":"792_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ccell.2015.08.003","volume":"28","author":"M Ramamoorthy","year":"2015","unstructured":"Ramamoorthy M, Smith S (2015) Loss of ATRX suppresses resolution of telomere cohesion to control recombination in ALT Cancer cells. Cancer Cell 28:357\u2013369. \n                    https:\/\/doi.org\/10.1016\/j.ccell.2015.08.003","journal-title":"Cancer Cell"},{"key":"792_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","volume":"136","author":"A Reinhardt","year":"2018","unstructured":"Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations. Acta Neuropathol 136:273\u2013291. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1837-8","journal-title":"Acta Neuropathol"},{"key":"792_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-010-0784-9","volume":"121","author":"EF Rodriguez","year":"2011","unstructured":"Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, Gilmer-Flynn H, Sarkaria JN, Jenkins S, Long J et al (2011) PI3K\/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 121:407\u2013420. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0784-9","journal-title":"Acta Neuropathol"},{"issue":"1","key":"792_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bpa.12646","volume":"29","author":"Fausto J. Rodriguez","year":"2018","unstructured":"Rodriguez FJ, Brosnan-Cashman JA, Allen SJ, Vizcaino MA, Giannini C, Camelo-Piragua S, Webb M, Matsushita M, Wadhwani N, Tabbarah A et al (2018) Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia. Brain Pathol: Doi. \n                    https:\/\/doi.org\/10.1111\/bpa.12646","journal-title":"Brain Pathology"},{"key":"792_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","volume":"67","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C (2008) Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67:240\u2013249. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e318165eb75","journal-title":"J Neuropathol Exp Neurol"},{"key":"792_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00401-016-1619-0","volume":"132","author":"FJ Rodriguez","year":"2016","unstructured":"Rodriguez FJ, Vizcaino MA, Blakeley J, Heaphy CM (2016) Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas. Acta Neuropathol 132:761\u2013763. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1619-0","journal-title":"Acta Neuropathol"},{"key":"792_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/modpathol.2015.134","volume":"29","author":"IM Schaefer","year":"2016","unstructured":"Schaefer IM, Fletcher CD, Hornick JL (2016) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29:4\u201313. \n                    https:\/\/doi.org\/10.1038\/modpathol.2015.134","journal-title":"Mod Pathol"},{"key":"792_CR41","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.molonc.2015.02.003","volume":"9","author":"K Simpson","year":"2015","unstructured":"Simpson K, Jones RE, Grimstead JW, Hills R, Pepper C, Baird DM (2015) Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients. Mol Oncol 9:1186\u20131193. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2015.02.003","journal-title":"Mol Oncol"},{"key":"792_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tonjes M, Sill M, Bender S et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2012.08.024","journal-title":"Cancer Cell"},{"key":"792_CR43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ng.3116","volume":"46","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wang Y, Jones S, Sausen M, McMahon K, Sharma R, Wang Q, Belzberg AJ, Chaichana K, Gallia GL et al (2014) Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet 46:1170\u20131172. \n                    https:\/\/doi.org\/10.1038\/ng.3116","journal-title":"Nat Genet"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0792-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:27:06Z","timestamp":1598484426000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0792-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0792-5","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"139"}}